Amber Specialty Pharmacy Selected To Dispense NEMLUVIO® (nemolizumab-ilto) by Galderma for Prurigo Nodularis
Amber
SEPTEMBER 12, 2024
12, 2024) – Amber Specialty Pharmacy, a leader in the specialty pharmacy industry, is excited to announce the availability of Galderma’s latest medication, NEMLUVIO® (nemolizumab-ilto), for the treatment of Prurigo Nodularis in adults. Omaha, Neb. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Let's personalize your content